U.S. Bone Marrow Biopsy Market to 2032
Overview
The U.S. Bone Marrow Biopsy Market is expected to reach a 109.73 USD Billion by 2032 and is projected to grow at a CAGR of 10.79% from 2025 to 2032.
Revenue, 2024 (USD Billion)
66.54
Forecast, 2032 (USD Billion)
109.73
CAGR, 2024 - 2032
10.79%
Report Coverage
U.S.
U.S. Bone Marrow Biopsy Market 2018-2032 USD Billion
U.S. Bone Marrow Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 66.54 USD Billion
- Projected Market Size (2032): 109.73 USD Billion
- CAGR (2025-2032): 10.79%
Key Findings of U.S. Bone Marrow Biopsy Market
- The U.S. Bone Marrow Biopsy Market was valued at 66.54 USD Billion in 2024.
- The U.S. Bone Marrow Biopsy Market is likely to grow at a CAGR of 10.79% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Core Needle Biopsy in Biopsy Type Segment accounted for the largest share of the market with a revenue of 53.21 USD Billion
- The fastest growing segment Flow Cytometry in Technique Segment grew Fastest with a CAGR of 13.54% during the forecast period from 2024 to 2032.
U.S. Bone Marrow Biopsy Market Scope
U.S. Bone Marrow Biopsy Market Segmentation & Scope
Product Type
- Others
- Procedure Trays
- Biopsy Gun
- Instruments
- Needles
- Needles, By Type
- Needles, By Modality
- Needles, By Ergonomics
Technique
- Others
- Karyotype Test
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Flow Cytometry
Age
- Pediatric
- Adult
- Geriatric
Application
- Others
- Aplastic Anemia
- Myelofibrosis
- Thrombocythemia
- Multiple Myeloma
- Polycythemia Vera
- Leukemia
- Lymphoma Disease
End User
- Others
- Academic and Research Organizations
- Ambulatory Surgical Centers
- Diagnostic Centers
- Hospitals
Biopsy Type
- Fine Needle Aspiration Biopsy
- Vacuum-Assisted Biopsy (VAB)
- Core Needle Biopsy
Procedure Type
- Others
- Tibia (Shin) Biopsy
- Percutaneous Trephine Biopsy
- Breastbone (Sternum) Biopsy
- Hip Biopsy
Site
- Others
- Proximal Humerus
- Proximal Tibia
- Distal Tibia
- Calcaneus
- Anterior Iliac Crest
- Posterior Iliac Crest
Distribution Channel
- Retail Sales
- Direct Tender
U.S. Bone Marrow Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 66.54 USD Billion |
| Market Value in 2032 | 109.73 USD Billion |
| CAGR (2025-2032) | 10.79% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Technique,Age,Application,End User,Biopsy Type,Procedure Type,Site,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 66.54 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 66.54 USD Billion in 2024.
Segments and Scope
-
U.S. Bone Marrow Biopsy Market to 2032, By Product Type
- Needles is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 48.65 USD Billion in the year 2024.
- Needles is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.12 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Technique
- Flow Cytometry is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 26.92 USD Billion in the year 2024.
- Flow Cytometry is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 13.54 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Age
- Geriatric is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 40.13 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 12.49 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Application
- Lymphoma Disease is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 33.38 USD Billion in the year 2024.
- Leukemia is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.59 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By End User
- Hospitals is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 35.86 USD Billion in the year 2024.
- Diagnostic Centers is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.10 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Biopsy Type
- Core Needle Biopsy is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 53.21 USD Billion in the year 2024.
- Core Needle Biopsy is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.04 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Procedure Type
- Hip Biopsy is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 38.42 USD Billion in the year 2024.
- Hip Biopsy is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.86 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Site
- Posterior Iliac Crest is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 32.24 USD Billion in the year 2024.
- Posterior Iliac Crest is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 12.55 % in forecast period 2025-2032.
-
U.S. Bone Marrow Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Bone Marrow Biopsy Market to 2032 with a revenue of 52.65 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Bone Marrow Biopsy Market to 2032 with a Growth rate of 11.81 % in forecast period 2025-2032.
U.S. Bone Marrow Biopsy Market Company Share Analysis
| Company Name |
|
||
| Merit Medical Systems | |||
| Medtronic | |||
| Teleflex Incorporated | |||
| Cardinal Health | |||
| ARGON MEDICAL | |||
U.S. Bone Marrow Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Bone Marrow Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Bone Marrow Biopsy Market is segmented based on Segmentation Product Type,Technique,Age,Application,End User,Biopsy Type,Procedure Type,Site,Distribution Channel.
U.S. Bone Marrow Biopsy Market was valued at USD 66.54(Revenue in USD Billion) in 2019.
U.S. Bone Marrow Biopsy Market is projected to grow at a CAGR of 10.79% during the forecast period of 2024 to 2032.
The Core Needle Biopsy segment is expected to dominate the U.S. Bone Marrow Biopsy Market, holding a largest market share of 53.21 USD Billion in 2024
U.S. Bone Marrow Biopsy Market Scope
U.S. Bone Marrow Biopsy Market Segmentation & Scope
Product Type
- Others
- Procedure Trays
- Biopsy Gun
- Instruments
- Needles
- Needles, By Type
- Needles, By Modality
- Needles, By Ergonomics
Technique
- Others
- Karyotype Test
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Flow Cytometry
Age
- Pediatric
- Adult
- Geriatric
Application
- Others
- Aplastic Anemia
- Myelofibrosis
- Thrombocythemia
- Multiple Myeloma
- Polycythemia Vera
- Leukemia
- Lymphoma Disease
End User
- Others
- Academic and Research Organizations
- Ambulatory Surgical Centers
- Diagnostic Centers
- Hospitals
Biopsy Type
- Fine Needle Aspiration Biopsy
- Vacuum-Assisted Biopsy (VAB)
- Core Needle Biopsy
Procedure Type
- Others
- Tibia (Shin) Biopsy
- Percutaneous Trephine Biopsy
- Breastbone (Sternum) Biopsy
- Hip Biopsy
Site
- Others
- Proximal Humerus
- Proximal Tibia
- Distal Tibia
- Calcaneus
- Anterior Iliac Crest
- Posterior Iliac Crest
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The U.S. Bone Marrow Biopsy Market is segmented based on Segmentation Product Type,Technique,Age,Application,End User,Biopsy Type,Procedure Type,Site,Distribution Channel.
U.S. Bone Marrow Biopsy Market was valued at USD 66.54(Revenue in USD Billion) in 2019.
U.S. Bone Marrow Biopsy Market is projected to grow at a CAGR of 10.79% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Bone Marrow Biopsy Market for final year is USD 109.73 (USD Billion).
U.S. Bone Marrow Biopsy Market Company Profiling
Frequently Asked Questions
The U.S. Bone Marrow Biopsy Market is segmented based on Segmentation Product Type,Technique,Age,Application,End User,Biopsy Type,Procedure Type,Site,Distribution Channel.
U.S. Bone Marrow Biopsy Market was valued at USD 66.54(Revenue in USD Billion) in 2019.
U.S. Bone Marrow Biopsy Market is projected to grow at a CAGR of 10.79% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Bone Marrow Biopsy Market for final year is USD 109.73 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.